Results 21 to 30 of about 164,355 (372)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

Pathogens, 2023
Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease, especially in young children. Despite its global impact on healthcare, related to its high prevalence and its association with significant morbidity, the ...
D. Gatt, I. Martin, R. Alfouzan, T. Moraes   +3 more
semanticscholar   +1 more source

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

Nature Communications, 2021
Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection with the most severe disease in the young and elderly.
John-Sebastian Eden, C. Sikazwe, Ruopeng Xie, Yi-Mo Deng, Sheena G. Sullivan, Alice Michie, A. Levy, Elena J Cutmore, C. Blyth, P. Britton, N. Crawford, Xiaomin Dong, D. Dwyer, Kimberly M. Edwards, B. Horsburgh, D. Foley, K. Kennedy, C. Minney-Smith, D. Speers, R. Tulloch, E. Holmes, V. Dhanasekaran, David W Smith, J. Kok, I. Barr   +24 more
semanticscholar   +1 more source

Antiviral therapy in current clinical practice: Respiratory virus infections

Sri Lankan Journal of Infectious Diseases, 2023
No abstract ...
S. N. Janage
doaj   +1 more source

Co-Infection Rates between SARS-CoV-2 and RSV in Oropharyngeal, Nasopharyngeal Aspirate and Saliva Samples of COVID-19 Patients, Shiraz, South of Iran [PDF]

Journal of Dentistry, 2023
Statement of the Problem: Determining the prevalence of respiratory viruses' coinfection with coronavirus disease 2019 (COVID-19) is essential to defining its true clinical influence.Purpose: This study aimed to evaluate co-infection rates between severe
Jannan Ghapanchi, Ali Dehghani Nazhvani, Fahimeh Rezazadeh, MItra Farzin, Afagh Moatari, Sina Masoudi, Mohamad Reza Kalantari, Reza Derafshi, Hossein Sedarat   +8 more
doaj   +1 more source

Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge

Human Vaccines & Immunotherapeutics, 2020
Although respiratory syncytial virus (RSV) infection in infants and young children is a global public health issue, development of a safe RSV vaccine has been impeded by formalin-inactivated RSV-enhanced respiratory disease (ERD).
Shuren Zhang, Gan Zhao, Caixia Su, Chaofan Li, Xian Zhou, Weidong Zhao, Yiwei Zhong, Zhonghuai He, Haichang Peng, Aihua Dong, Bin Wang   +10 more
doaj   +1 more source

Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States

Infectious Disease and Therapy, 2023
Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)-related hospitalizations in older adults. Without RSV-specific treatment for adults, testing is uncommon, leading to potential underestimation ...
M. Rozenbaum, Jennifer Judy, D. Tran, K. Yacisin, S. Kurosky, Elizabeth Begier   +5 more
semanticscholar   +1 more source

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.

New England Journal of Medicine, 2020
BACKGROUND Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants, and a need exists for prevention of RSV in healthy infants.
M. P. Griffin, Yuan Yuan, Therese Takas, J. Domachowske, S. Madhi, P. Manzoni, E. Simões, M. Esser, Anis A. Khan, F. Dubovsky, T. Villafana, J. DeVincenzo   +11 more
semanticscholar   +1 more source

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

Frontiers in Immunology, 2022
Respiratory syncytial virus (RSV) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalizations and a substantial number of outpatient visits, which result in a huge economic and healthcare burden.
S. Esposito, B. Abu Raya, Eugenio Baraldi, K. Flanagan, F. Martinón Torres, M. Tsolia, S. Zielen   +6 more
semanticscholar   +1 more source

SARS-CoV-2 Vaccines: A Brief Review

Pediatric Respirology and Critical Care Medicine, 2020
SARS-CoV-2 has immensely changed the landscape in how vaccines are researched and developed. The timeline truncated for the propose of meeting the grave demand. Children stand to benefit from herd immunity for multiple reasons. Protection from SARS-CoV-2
Brandon Chatani, Daniel K. Ng
doaj   +1 more source

Maternal RSV vaccine development. Where to from here?

Human Vaccines & Immunotherapeutics, 2021
Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infection and is responsible for a large proportion of infant morbidity and mortality worldwide.
Ahinsa Gunatilaka, Michelle L. Giles
doaj   +1 more source